Abstract Background-Self-expanding metal stents have been used successfully to overcome large airway obstruction due to malignant pulmonary disease. The technique has been modified to place stents under direct vision using the fibreoptic bronchoscope. The effect of this procedure on lung function and patient well being was investigated in a large series of patients. Methods -Fifty six patients with malignant tracheobronchial tumours were treated for symptoms of life threatening airways obstruction or collapse of a lung by the insertion of an expandable metal stent(s) under local anaesthetic using a fibreoptic bronchoscope. All had inoperable cancer and 33 had relapsed after or failed to respond to radiotherapy, chemotherapy, or surgery. Forty seven had primary bronchial carcinomas and nine had metastases from other tumour sites. All but two patients had the stents inserted at one sitting. Measurements were performed in most ofthe patients before and after stenting and included objective measures (pulmonary function tests, arterial blood gas tensions) and non-objective measures (patient well being, performance status). (Thorax 1996;51:248-252) 
Treatment of large airway obstruction in lung cancer using expandable metal stents inserted under direct vision via the fibreoptic bronchoscope G E Wilson, M J Walshaw, C R K Hind Abstract Background-Self-expanding metal stents have been used successfully to overcome large airway obstruction due to malignant pulmonary disease. The technique has been modified to place stents under direct vision using the fibreoptic bronchoscope. The effect of this procedure on lung function and patient well being was investigated in a large series of patients. Methods -Fifty six patients with malignant tracheobronchial tumours were treated for symptoms of life threatening airways obstruction or collapse of a lung by the insertion of an expandable metal stent(s) under local anaesthetic using a fibreoptic bronchoscope. All had inoperable cancer and 33 had relapsed after or failed to respond to radiotherapy, chemotherapy, or surgery. Forty seven had primary bronchial carcinomas and nine had metastases from other tumour sites. All but two patients had the stents inserted at one sitting. Measurements were performed in most ofthe patients before and after stenting and included objective measures (pulmonary function tests, arterial blood gas tensions) and non-objective measures (patient well being, performance status). Results -Overall, 77% of patients showed symptomatic improvement. In those patients in whom measurements were performed two thirds showed improvement in forced expiratory volume in one second (FEV1), forced vital capacity (FVC), peak expiratory flow rate (PEFR) and arterial oxygen tension (Pao2). Medical Research Council dyspnoea score (MRC), Kar- Large airway obstruction due to primary lung cancer or spread from non-bronchial malignancies can produce life threatening and distressing breathlessness, either as an acute presenting symptom of the underlying disease or when recurrence occurs after other treatment. Expandable metal stents have been used successfully to relieve airway obstruction in such patients.'2 In these case reports the procedure was carried out under general anaesthesia using a rigid bronchoscope and fluoroscopic imaging. This approach limits its use to centres where rigid bronchoscopy is available, and to those patients who are well enough to withstand general anaesthesia.
To overcome these difficulties we have modified the procedure by inserting these expandable stents under direct vision using a fibreoptic bronchoscope and local anaesthesia only. We report here our experience of this novel approach in 56 patients, and our assessment of the effectiveness of this therapy in the palliation of inoperable lung cancer.
Methods
A total of 56 patients with respiratory distress due to malignant obstruction of the trachea and/or a main bronchus have now undergone this procedure (33 men) of mean age 64 years (range 30-82). Forty seven had primary bronchial carcinomas and nine had endobronchial metastases from a cancer elsewhere in the body (table 1) . Of the 56 patients 33 had suffered relapse after conventional treatment with radio- The 56 patients were treated over a three year period. The stents used (see below) are available in a range of widths and lengths. In this study we used the following sizes: 20 mm (width) x 25 mm (length), 20 mm x 50 mm, 30 mm x 25 mm, and 30 mm x 50 mm. In general the 20 mm width stents were used for obstruction in the main bronchi and 30 mm stents for obstruction in the trachea.
Response to treatment was firstly assessed by the patient's account of their symptoms (using a visual analogue score for breathing and another for well being). The Medical Research Council (MRC) score of breathlessness3 and the Kamofsky index4 were then completed by a doctor. Secondly, the results of lung function studies before and after stenting were recorded including forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and peak expiratory flow rate (PEFR) measured on a Jaeger Masterlab system. Arterial blood gas tensions were also measured before and after stenting. However, not all of the prestenting assessments could be completed in some patients because of extreme breathlessness or where the stenting was carried out as an emergency when the facilities were not available. Where measurements were able to be carried out the prestenting values were obtained within the preceding 24 hours (or less), and the poststenting values were obtained up to 72 hours after stenting. The visual analogue scores of breathlessness and well being consist of a 100 mm analogue scale. The ends of the scale are marked "very, very breathless" and "not at all breathless" and "very, very ill" and "very, very well", respectively. The patients placed a mark on the 100 mm scale to indicate how they felt at the time of each assessment. A score of 0 mm was the worst possible and 100 mm the best.
The results were analysed using the Student's t test for paired samples on Minitab statistical software. A p value of 0 05 was considered significant.
Each patient received our standard regimen of intravenous sedation with droperidol and fentanyl (neuraleptanalgesia), a transtracheal injection of 5% cocaine, and spraying of the pharynx with topical xylocaine. All patients received supplementary oxygen via nasal cannulae (61/min), and oxygen saturation was monitored using an oximeter attached via a finger probe. 
Discussion
There are now a number of treatment options available for the relief of distressing breathlessness due to major airway compression from inoperable carcinomas. These include endoscopic surgery,6 cryotherapy,7 laser photoresection,8 and the insertion of silastic9 or selfexpanding metal stents. l2 All are usually undertaken via a rigid bronchoscope using general anaesthesia, thereby limiting their application to centres where these facilities are available.
The results presented here demonstrate that self-expanding metal stents can be inserted under local anaesthesia using the direct vision afforded by a fibreoptic bronchoscope. In our view this could be carried out in any centre where fibreoptic bronchoscopy is available. However, facilities to transfer a patient to a centre offering rigid bronchoscopy should be available in case patients cannot tolerate a fibreoptic bronchoscopy. Rigid bronchoscopy is also indicated for the removal of stents that have been positioned incorrectly. As reported previously,'0 these stents can be removed up to two weeks after their insertion using rigid bronchoscopy forceps. Thereafter, the stent is covered with tracheobronchial mucosa and, indeed, may not be visible endoscopically after a few months.
In our series stenting was carried out either as a primary palliative procedure or secondary after other therapies. 
